Sirolimus Amelioration of Clinical Symptoms of Recurrent Lymphangioleiomyomatosis After Living-donor Lobar Lung Transplantation
- 31 August 2008
- journal article
- case report
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 27 (8), 921-924
- https://doi.org/10.1016/j.healun.2008.05.012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Regression of Pulmonary Lymphangioleiomyomatosis (PLAM)-associated Retroperitoneal Angiomyolipoma Post–Lung Transplantation With Rapamycin TreatmentThe Journal of Heart and Lung Transplantation, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisThe New England Journal of Medicine, 2008
- Lung Transplantation in the Management of Patients With Lymphangioleiomyomatosis: Baseline Data From the NHLBI LAM RegistryThe Journal of Heart and Lung Transplantation, 2007
- Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Lung and Heart–Lung Transplantation Report—2007The Journal of Heart and Lung Transplantation, 2007
- Immunosuppression for Lung TransplantationDrugs, 2007
- Recurrent Lymphangioleiomyomatosis After Living-Donor Lobar Lung TransplantationTransplantation Proceedings, 2006
- Lymphangiogenesis-Mediated Shedding of LAM Cell Clusters as a Mechanism for Dissemination in LymphangioleiomyomatosisThe American Journal of Surgical Pathology, 2005
- Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppressionThe Journal of Heart and Lung Transplantation, 2004
- Lung transplantation for lymphangioleiomyomatosisThe Journal of Heart and Lung Transplantation, 2004
- Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1995